Hi Lockitt
Thank you for your input re “gaps”
it’s your opinion and I’m happy to read it .
However
This is a Biotech which is tightly held and even more now since the accumulator has being buying up for the past 6 months..
Todays news is a blockbuster : it validates the Atl1102 Science…
Now
Most of the Board and GT are going to the US in early June.
Presenting posters. Speaking .. and meeting future Partners
I’m very confident the FDA will not approve Sareptas SRP901( gene therapy) for the whole DMD population
Atl1102 will be the focus at the PPMD meeting also in June.
So much happening
We should hear more ….shortly $$
Hi LockittThank you for your input re “gaps”it’s your opinion...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.5¢ |
Change
0.002(2.41%) |
Mkt cap ! $76.63M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.7¢ | 8.2¢ | $57.91K | 686.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12000 | 8.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 5978 | 1 |
View Market Depth
| Last trade - 15.23pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.4¢ |
Change
0.002 ( 1.20 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.5¢ | 8.1¢ | 42939 | ||
| Last updated 15.42pm 12/06/2024 ? | |||||
| PER (ASX) Chart |